N-[2-(2-tert-butylphenoxy)ethyl]-2-[3-(1-hydroxyethenyl)-4-pyridinyl]-N-methylacetamide
C22H28N2O3 — CID 161451755
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(2-tert-butylphenoxy)ethyl]-2-[3-(1-hydroxyethenyl)-4-pyridinyl]-N-methylacetamide
N-[2-(2-tert-butylphenoxy)ethyl]-2-[3-(1-hydroxyethenyl)-4-pyridinyl]-N-methylacetamide (PubChem CID 161451755) has the molecular formula C22H28N2O3 and a molecular weight of 368.48 g/mol. Its IUPAC name is N-[2-(2-tert-butylphenoxy)ethyl]-2-[3-(1-hydroxyethenyl)-4-pyridinyl]-N-methylacetamide.
Molecular Properties
| Compound Name | N-[2-(2-tert-butylphenoxy)ethyl]-2-[3-(1-hydroxyethenyl)-4-pyridinyl]-N-methylacetamide |
|---|---|
| PubChem CID | 161451755 |
| Molecular Formula | C22H28N2O3 |
| Molecular Weight | 368.48 g/mol |
| Exact Mass | 368.21 |
| IUPAC Name | N-[2-(2-tert-butylphenoxy)ethyl]-2-[3-(1-hydroxyethenyl)-4-pyridinyl]-N-methylacetamide |
| SMILES | C=C(O)c1cnccc1CC(=O)N(C)CCOc1ccccc1C(C)(C)C |
| InChI | InChI=1S/C22H28N2O3/c1-16(25)18-15-23-11-10-17(18)14-21(26)24(5)12-13-27-20-9-7-6-8-19(20)22(2,3)4/h6-11,15,25H,1,12-14H2,2-5H3 |
| InChIKey | GNLNSNPMQWFZSA-UHFFFAOYSA-N |
| XLogP | 3.99 |
| TPSA | 62.66 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 368.48 |
| LogP ≤ 5 | 3.99 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161451755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.